Genetic Testing Global Market by Product, Scope, Analysis and Outlook to 2022
ReportsWeb.com published “Genetic Testing Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 04, 2018 ) According to Publisher, the Global Genetic Testing market accounted for $3.5 billion in 2015 and is expected to reach $6.0 billion by 2022 growing at a CAGR of 8.2% from 2015 to 2022. Genetic tests have revolutionized the molecular diagnostics market. Factors such as growing awareness, technological advancements in genetic sequencing, advancement in DNA analysis, early diagnosis and personalized medicines are driving the market growth. Growing incidence of genetic diseases and screening new-born babies or embryos for genetic defects will provide wider opportunities. The lack of governmental regulation and the potential misinterpretation of genetic information as well as ethical issues will challenge the market. Lack of reimbursement & medical coverage and high cost of the procedures will restrain the market growth.
For more information http://www.reportsweb.com/genetic-testing-global-market-outlook-2016-2022
Diagnostic testing and Newborn screening application have projected to grow in the market. The Carrier Testing market is expected to witness the highest growth during the forecast period and Cancer genetic testing commanding the largest market share. North America dominated the global market followed by Europe. Asia Pacific is the fastest growing market led by China.
Some of the key players in global Genetic Testing market are Abbott Laboratories, Biocartis SA, Applied Biosystems Inc, Celera Group, AutoGenomics Inc, Roche Diagnostics Limited, IntegraGen S.A, Transgenomic, Inc, Molecular Inc, Luminex Corporation , Quest Diagnostics Inc, PerkinElmer Inc, BioRad Laboratories, ELITech Group, Agilent Technologies Inc and Thermo Fisher Scientific.
Applications Covered:
-Cancer Genetic Testing
-Prenatal Genetic Testing
-Pharmacogenomics Genetic Testing
-Predisposition Cancer Genetic Testing
Types Covered:
- Carrier testing
-Diagnostic testing
-Newborn screening
-Prenatal testing
-Predictive & Pre-symptomatic testing
Technologies Covered:
-Cytogenetic testing
-Biochemical testing
-Molecular testing
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001390844/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
10 Company Profiling
10.1 Abbott Laboratories
10.2 Biocartis SA
10.3 Applied Biosystems Inc.
10.4 Celera Group
10.5 AutoGenomics Inc.
10.6 Roche Diagnostics Limited
10.7 IntegraGen S.A
10.8 Transgenomic, Inc.
10.9 Molecular Inc.
10.10 Luminex Corporation
10.11 Quest Diagnostics Inc
10.12 PerkinElmer Inc
10.13 BioRad Laboratories
10.14 ELITech Group
10.15 Agilent Technologies Inc
10.16 Thermo Fisher Scientific
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001390844/buying
For more information http://www.reportsweb.com/genetic-testing-global-market-outlook-2016-2022
Diagnostic testing and Newborn screening application have projected to grow in the market. The Carrier Testing market is expected to witness the highest growth during the forecast period and Cancer genetic testing commanding the largest market share. North America dominated the global market followed by Europe. Asia Pacific is the fastest growing market led by China.
Some of the key players in global Genetic Testing market are Abbott Laboratories, Biocartis SA, Applied Biosystems Inc, Celera Group, AutoGenomics Inc, Roche Diagnostics Limited, IntegraGen S.A, Transgenomic, Inc, Molecular Inc, Luminex Corporation , Quest Diagnostics Inc, PerkinElmer Inc, BioRad Laboratories, ELITech Group, Agilent Technologies Inc and Thermo Fisher Scientific.
Applications Covered:
-Cancer Genetic Testing
-Prenatal Genetic Testing
-Pharmacogenomics Genetic Testing
-Predisposition Cancer Genetic Testing
Types Covered:
- Carrier testing
-Diagnostic testing
-Newborn screening
-Prenatal testing
-Predictive & Pre-symptomatic testing
Technologies Covered:
-Cytogenetic testing
-Biochemical testing
-Molecular testing
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001390844/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
10 Company Profiling
10.1 Abbott Laboratories
10.2 Biocartis SA
10.3 Applied Biosystems Inc.
10.4 Celera Group
10.5 AutoGenomics Inc.
10.6 Roche Diagnostics Limited
10.7 IntegraGen S.A
10.8 Transgenomic, Inc.
10.9 Molecular Inc.
10.10 Luminex Corporation
10.11 Quest Diagnostics Inc
10.12 PerkinElmer Inc
10.13 BioRad Laboratories
10.14 ELITech Group
10.15 Agilent Technologies Inc
10.16 Thermo Fisher Scientific
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001390844/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results